Davita (DVA) Cash & Equivalents (2009 - 2026)

Davita has disclosed Cash & Equivalents across 18 years of filings, most recently posting $644.2 million for Q1 2026.

• In Q1 2026, Cash & Equivalents rose 46.83% year-over-year to $644.2 million; the TTM figure through Mar 2026 stood at $644.2 million (up 46.83% YoY), while the FY2025 annual figure was $676.4 million, down 14.91% from the prior year.
• Cash & Equivalents retreated to $644.2 million in Q1 2026, from $676.4 million in the prior quarter.
• Over the last five years, Cash & Equivalents for DVA reached as high as $1.1 billion in Q3 2024 and fell as low as $244.1 million in Q4 2022.
• The 5-year median for Cash & Equivalents is $416.5 million (2024), against an average of $498.6 million.
• Annual changes were most pronounced in 2022 — Cash & Equivalents tumbled 74.84% — and 2024, when it surged 138.24%.
• A 5-year view of Cash & Equivalents shows it stood at $244.1 million in 2022, then soared by 55.71% to $380.1 million in 2023, then soared by 109.16% to $794.9 million in 2024, then slipped by 14.91% to $676.4 million in 2025, then retreated by 4.76% to $644.2 million in 2026.
• According to Business Quant data, Cash & Equivalents over the past three periods registered $644.2 million, $676.4 million, and $706.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.